US 8263651
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
granted A61KA61K31/17A61K31/192
Quick answer
US patent 8263651 (Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors) held by The Regents of the University of California expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/17, A61K31/192, A61K31/202, A61K31/335